Rheumatology

Musculoskeletal (MSK) pain and soft tissue injuries are very common both in sportspeople and in the general population and include different forms of traumas that must be properly treated to allow the return to normal life or sports activities.

In this session chaired by Prof. Baraliakos, Prof. Nash and Prof. Machado discuss advances in artificial intelligence and machine learning that could potentially aid in the diagnosis and management of axSpA and PsA.

In this short summary video, Prof. Gottlieb discusses the role dermatologists can play in detecting PsA as well as the diagnostic tools that can be used to help achieve an early diagnosis.

In this short summary video, Prof. Mease discusses the need for consensus on the definition and classification criteria for the axial manifestation of PsA, also highlighting the need for specific clinical assessments and clinical trials designed to investigate the efficacy of therapy options in this patient population.

Methotrexate has been established beyond doubt as the primary disease-modifying drug for the therapy of rheumatoid arthritis.

In this webinar Dr. Jonathan Sackier is joined by Dr. Alia Darweish Medniuk and Dr. Juraj Kacian as they discuss the importance of the NSAID diclofenac for the management of pain in different settings/clinical situations. They will also highlight what’s new for diclofenac, namely the development of new formulations at small volume and low dosages, in line with the EMA recommendations on NSAIDs and CV risk

Investigating osteoarthritis (OA), a long-term chronic disease that is increasing year on year due to population ageing and growth in related factors such as obesity.

Delve into the venue for this year’s European League Against Rheumatism (EULAR) Congress.